RxDoctor Payments Data

Helene Alphonso, DO

Psychiatry · Euless, TXNPI 1972779734

Payments from drug & device makers

$637in general payments, 2019–2025

Across 26 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$198
  • Sunovion Pharmaceuticals Inc.$185
  • Neurocrine Biosciences, Inc.$83
  • Alkermes, Inc.$45
  • AbbVie$44
  • Johnson & Johnson$38
  • plus $44 from 2 others

What the payments were for

  • Food & beverage$41866%
  • Education$21834%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$637 in reported general payments places this provider in the 60th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$32,899
Medicare patients
132
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate22$178,877
Invega TrinzaPaliperidone Palmitate19$170,758
Invega SustennaPaliperidone Palmitate28$92,400
AristadaAripiprazole Lauroxil15$51,774
Abilify MaintenaAripiprazole13$35,121
Lurasidone Hcl15$20,484
VivitrolNaltrexone Microspheres11$18,517
Aripiprazole28$5,758
DayvigoLemborexant11$3,494
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$2,368
Carbamazepine ErCarbamazepine20$1,795
Duloxetine Hcl46$1,728
Oxcarbazepine12$1,718
Quetiapine Fumarate43$1,480
Clozapine11$1,423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$38$263,15847 claims
Neurocrine Biosciences, Inc.Ingrezza$83$178,87722 claims
Alkermes, Inc.Aristada, Vivitrol$45$70,29126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Euless

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →